Genetic proxies for therapy of insulin drug targets and risk of osteoarthritis: a drug-target Mendelian randomization analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Genetic proxies for therapy of insulin drug targets and risk of osteoarthritis: a drug-target Mendelian randomization analysis ; day:11 ; month:8 ; year:2024 ; pages:1-12
Inflammopharmacology ; (11.8.2024), 1-12
- Creator
-
Cao, Ziqin
Li, Qiangxiang
Wu, Jianhuang
Li, Yajia
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10787-024-01542-8
- URN
-
urn:nbn:de:101:1-2410292114446.705440058339
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cao, Ziqin
- Li, Qiangxiang
- Wu, Jianhuang
- Li, Yajia
- SpringerLink (Online service)
Other Objects (12)
Exploring drug-target interaction networks of illicit drugs
Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study
Drug–target interaction prediction via multiple classification strategies
Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study
Exploring the causal effect between lipid-modifying drugs and idiopathic pulmonary fibrosis: a drug-target Mendelian randomization study
DASPfind: new efficient method to predict drug–target interactions
Explainable deep drug–target representations for binding affinity prediction
Prediction of drug–target interactions through multi-task learning
GSRF-DTI: a framework for drug-target interaction prediction based on a drug-target pair network and representation learning on a large graph
Drug combinatorics and side effect estimation on the signed human drug-target network
New evidence: Metformin unsuitable as routine adjuvant for breast cancer: a drug-target mendelian randomization analysis
Assessing the safety of lipid-modifying medications among Chinese adolescents: a drug-target Mendelian randomization study
Exploring drug-target interaction networks of illicit drugs
Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study
Drug–target interaction prediction via multiple classification strategies
Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study
Exploring the causal effect between lipid-modifying drugs and idiopathic pulmonary fibrosis: a drug-target Mendelian randomization study
DASPfind: new efficient method to predict drug–target interactions
Explainable deep drug–target representations for binding affinity prediction
Prediction of drug–target interactions through multi-task learning
GSRF-DTI: a framework for drug-target interaction prediction based on a drug-target pair network and representation learning on a large graph
Drug combinatorics and side effect estimation on the signed human drug-target network
New evidence: Metformin unsuitable as routine adjuvant for breast cancer: a drug-target mendelian randomization analysis
Assessing the safety of lipid-modifying medications among Chinese adolescents: a drug-target Mendelian randomization study
Exploring drug-target interaction networks of illicit drugs
Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study
Drug–target interaction prediction via multiple classification strategies
Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study
Exploring the causal effect between lipid-modifying drugs and idiopathic pulmonary fibrosis: a drug-target Mendelian randomization study
DASPfind: new efficient method to predict drug–target interactions
Explainable deep drug–target representations for binding affinity prediction
Prediction of drug–target interactions through multi-task learning
GSRF-DTI: a framework for drug-target interaction prediction based on a drug-target pair network and representation learning on a large graph
Drug combinatorics and side effect estimation on the signed human drug-target network
New evidence: Metformin unsuitable as routine adjuvant for breast cancer: a drug-target mendelian randomization analysis